Twist Bioscience Announces Fiscal 2024 Fourth Quarter and Full Year Financial Results
Twist Bioscience (NASDAQ: TWST) announced its financial results for Q4 and full year fiscal 2024 ended September 30, 2024. The company will host a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time to discuss the results and provide a business update. Participants can access detailed earnings reports and investor presentations through the company's website. Those joining via telephone must register in advance to receive dial-in information.
Twist Bioscience (NASDAQ: TWST) ha annunciato i suoi risultati finanziari per il quarto trimestre e l'intero anno fiscale 2024 conclusosi il 30 settembre 2024. L'azienda ospiterà una conference call e una trasmissione audio dal vivo per analisti e investitori alle 8:00 ora orientale per discutere i risultati e fornire un aggiornamento aziendale. I partecipanti possono accedere ai rapporti sugli utili e alle presentazioni per gli investitori attraverso il sito web dell'azienda. Coloro che partecipano telefonicamente devono registrarsi in anticipo per ricevere le informazioni di accesso.
Twist Bioscience (NASDAQ: TWST) anunció sus resultados financieros para el cuarto trimestre y el año fiscal completo 2024 que finalizó el 30 de septiembre de 2024. La empresa llevará a cabo una conferencia telefónica y una transmisión de audio en vivo para analistas e inversores a las 8:00 a.m. hora del Este para discutir los resultados y proporcionar una actualización empresarial. Los participantes pueden acceder a informes detallados de ganancias y presentaciones para inversores a través del sitio web de la empresa. Aquellos que se unan por teléfono deben registrarse con anticipación para recibir información de acceso.
트위스트 바이오사이언스 (NASDAQ: TWST)는 2024 회계연도 4분기 및 전체 연도 재무 결과를 발표했습니다. 이 회사는 2024년 9월 30일 기준으로 재무 결과를 논의하고 사업 업데이트를 제공하기 위해 동부 표준시 오전 8시에 애널리스트와 투자자를 위한 컨퍼런스 콜 및 생중계 오디오 웹캐스트를 개최합니다. 참가자는 회사 웹사이트를 통해 상세한 수익 보고서 및 투자자 프레젠테이션에 접근할 수 있습니다. 전화로 참여하는 사람은 접속 정보를 받기 위해 사전 등록을 해야 합니다.
Twist Bioscience (NASDAQ: TWST) a annoncé ses résultats financiers pour le quatrième trimestre et l'exercice complet 2024, qui s'est terminé le 30 septembre 2024. L'entreprise organisera une conférence téléphonique et un webinaire audio en direct pour les analystes et les investisseurs à 8h00, heure de l'Est, afin de discuter des résultats et de fournir une mise à jour sur les activités. Les participants peuvent accéder aux rapports détaillés sur les bénéfices et aux présentations pour investisseurs via le site Web de l'entreprise. Ceux qui rejoignent par téléphone doivent s'inscrire à l'avance pour recevoir les informations d'appel.
Twist Bioscience (NASDAQ: TWST) hat seine finanziellen Ergebnisse für das vierte Quartal und das gesamte Geschäftsjahr 2024, das am 30. September 2024 endete, bekannt gegeben. Das Unternehmen wird um 8:00 Uhr Eastern Time eine Telefonkonferenz und einen Live-Audio-Webcast für Analysten und Investoren durchführen, um die Ergebnisse zu besprechen und ein Geschäftsupdate zu geben. Die Teilnehmer können detaillierte Gewinnberichte und Investorenpräsentationen über die Unternehmenswebsite einsehen. Anrufer müssen sich im Voraus registrieren, um die Einwahlinformationen zu erhalten.
- None.
- None.
Visit the Events and Presentations page of the Investor Relations section under the “Company” tab at www.twistbioscience.com to view the detailed fiscal fourth quarter and full year 2024 earnings report and the investor presentation, or click https://investors.twistbioscience.com/events-and-presentations.
The company plans to hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time today to discuss its financial results and provide an update on the company’s business. The conference call will be webcast live through the Investor Relations section under the “Company” tab at www.twistbioscience.com. Those parties interested in participating via telephone must register on the Company’s Investor Relations website or by clicking here. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be used to access the call. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast replay will be available for two weeks.
About Twist Bioscience Corporation
Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture, and academic research.
Follow us on LinkedIn | X | YouTube | Instagram
View source version on businesswire.com: https://www.businesswire.com/news/home/20241118673251/en/
For Investors:
Angela Bitting
SVP, Corporate Affairs
925-202-6211
abitting@twistbioscience.com
For Media:
Amanda Houlihan
Communications Manager
774-265-5334
ahoulihan@twistbioscience.com
Source: Twist Bioscience Corporation
FAQ
When did Twist Bioscience (TWST) release its Q4 and FY2024 earnings?
How can investors access Twist Bioscience's (TWST) Q4 2024 earnings call?
What time is Twist Bioscience's (TWST) Q4 2024 earnings call?
